Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/139392
Title: Risk management by the marketing authorisation holder in product quality review
Authors: Gauci, Jeremy
Azzopardi, Lilian M.
Attard Pizzuto, Maresca
Keywords: Drugs -- Quality control
Pharmaceutical industry -- Quality control
Pharmaceutical industry -- Risk management
Pharmaceutical technology -- Standards
Pharmacovigilance
Issue Date: 2025
Publisher: International Pharmaceutical Federation, Federation Internationale Pharmaceutique
Citation: Gauci, J., Azzopardi, L. M., & Attard Pizzuto, M. (2025). Risk management by the marketing authorisation holder in product quality review. Pharmacy Education, 25(4), 13-14.
Abstract: Introduction: Product Quality Reviews, forming part of the current Good Manufacturing Practices, are periodic product quality assessments of all authorised pharmaceutical products, including those intended for export only Product Quality Reviews are performed to ensure that the current specifications for raw materials and final products are appropriate and reliable, to identify any trends that the current manufacturing procedure is consistent and to determine ways to enhance both the product and the process The Marketing Authorisation Holder is responsible for conducting routine product reviews and audits of the manufacturing processes in addition to adhering to Good Manufacturing Practice.
Aim: To carry out a risk assessment, using Failure Mode and Effect Analysis, on the Product Quality Reviews performed by the Marketing Authorisation Holder to identify the risk imposed, if any, if the current checks are not executed
URI: https://www.um.edu.mt/library/oar/handle/123456789/139392
Appears in Collections:Scholarly Works - FacM&SPha



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.